Press release of Solamichi System Co., Ltd. (2024.11.13) Solamichi System Co., Ltd. Corte, an AI medication history creation support service jointly developed by Soramichi System and Corte, will be introduced at 50 Nippon Pharmacy stores! ～Improve the efficiency of medical procedures and further improve the quality of medical care and medication guidance Three companies cooperate with the aim of Corte*1, an AI drug history creation support service jointly developed by Soramichi System Co., Ltd. (hereinafter referred to as the “Company”) and Corte Co., Ltd. It has been introduced at all dispensing pharmacies operated by Nippon Chouzai (hereinafter referred to as “Nippon Chouzai”), and began providing it on Monday, November 11, 2024. “Corte” is a medication history input support tool that uses generated AI to automatically summarize conversations about medication guidance given by pharmacists to patients and displays them in text. By introducing this service, Nippon Chouzai aims to further improve the quality of medical care by reducing the time it takes to create drug histories, improving operational efficiency, and increasing the amount of time spent communicating with each patient. ◆Soramichi System x Nippon Choju x Corte collaborate to further improve the quality of medical care! We aim to support the creation of a system that allows us to focus on family pharmacists and pharmacies, including home-based care, by reducing the time and effort required to create drug records and improving operational efficiency. We jointly developed the creation support service “corte”. Since its launch in April 2024, it has been introduced at over 300 pharmacies*2. Nippon Chouzai, which operates dispensing pharmacies in 47 prefectures nationwide, strives to provide high-quality medical care to patients while responding to changes in the medical system and lifestyle. In order to respond quickly and appropriately to accelerating industry changes and diversifying patient needs, we mainly develop and operate our own systems, but also flexibly collaborate with other companies’ systems. This time, our company, Nippon Chouzai, and Corte will implement initiatives to improve the efficiency of medical procedures using Corte, with the aim of improving the quality of medical care and further improving medication guidance. ◆Utilize generative AI to help improve the efficiency of physical operations and strengthen interpersonal operations! Improving the medical experience for both patients and pharmacists The AI medication history creation support service “corte”, which will be introduced at dispensing pharmacies operated by Nippon Chouzai, records conversations by pharmacists while giving medication guidance to patients, and records information such as the actual contents of the instructions and symptoms reported by the patient. The AI that generates the information necessary for drug history automatically summarizes it and displays it in text. You can easily use it by simply pressing the recording button in “corte” before or after medication guidance, and you can check the automatically generated content and transcribe the necessary information to create a medication history *3. Using this function, pharmacists no longer need to take notes when giving medication instructions or transcribe them afterwards, thereby improving work efficiency by shortening the time it takes to write medication history, as well as increasing patient feedback. By allowing pharmacists to focus more on listening to symptoms and providing medication guidance, we also support improving the quality of pharmacists’ medication guidance.
https://prcdn.freetls.fastly.net/release_image/77012/62/77012-62-94584efd37b19c4a4367effd52275618-430×225.png
Automatically generates text in SOAP format*4, allowing smooth information sharing among medical and nursing care teams. (Output is possible in formats other than SOAP) Carefully enter numerical values such as number of prescription days and number of remaining medicines, as well as disease name and drug name. It can be used on computers, tablets, and smartphones, so it can be used even when visiting people at home. ■Comment from Yuichi Nagashima, Director of Pharmaceutical Planning and Marketing, Pharmaceutical Headquarters, Nippon Chouzai Co., Ltd. We are very happy to be able to introduce the AI drug history creation support service “corte” to 50 stores through our partnership with Solamichi System Co., Ltd. “corte” is a powerful tool that greatly improves the efficiency of
pharmacists’ medication guidance work and improves the quality of interpersonal work. Soramichi’s vision is to eliminate unnecessary waste in the medical field and provide optimal medical care for each individual, and with this philosophy and mission of “The best medical care with the best colleagues!” I sympathize deeply. I was
particularly impressed by Soramichi’s ability to accurately grasp the actual issues faced by pharmacies and develop technology to solve them. With the introduction of “corte,” pharmacists will be freed from handling duties and will be able to enhance communication with patients. This makes it possible to provide appropriate medication guidance tailored to each patient, greatly contributing to improving the quality of medical care. Through this initiative, we will provide patients with a better medical experience. ■Comment from Kiminori Nagano, Manager, Pharmaceutical Planning Department, Pharmaceutical Headquarters, Nippon Chouzai Co., Ltd. In charge of AI drug history implementation At Nippon Chouzai, we are promoting medical DX with the aim of further enhancing the interpersonal work of pharmacists and improving services for patients. As part of this effort, we have introduced drug history creation support using AI. AI technology goes beyond simply improving input efficiency and provides an environment where pharmacists can focus on providing medication guidance. Conventional medication history entry has had the issue of increasing the amount of memo work required to improve the quality of instruction, which lengthens patient waiting time and medication history processing time. By using AI, medication instructions can be recorded as is, allowing pharmacists to spend more time with patients. This is expected to significantly improve both the quality and quantity of services provided to patients. ■Comment from Yusuke Masuzawa, President and CEO of Corte Co., Ltd. We are very honored to be able to collaborate with Nippon Chuzai. “Corte” was developed with the aim of not only increasing work efficiency but also improving the quality of medication guidance. As the medical field becomes increasingly strained, we believe that pharmacies will play an important role in supporting the future health of the nation. This is because, as the closest medical institution in the region, we are able to be close to our patients and make suggestions based on their lifestyle habits. Therefore, by utilizing generative AI, we would like to reduce the burden of physical operations and enhance interpersonal operations. We will work together with Nippon Pharmacy, which shares this desire, to improve the medical experience. ■Comment from Takahiro Taura, President and CEO of Soramichi System Co., Ltd. Solamichi System’s mission is to “provide the best medical care with the best colleagues!” We work together with colleagues who have the common goal of “improving medical care in Japan,” transcending boundaries within and outside the company, to improve the value of pharmacies and pharmacists. We aim to improve the quality of medical care by providing services that contribute to the improvement of medical care. “Corte” not only streamlines pharmacists’ work with supplies, but also improves the quality of medication guidance and contributes to improving the overall quality of medical care. The recent introduction of “corte” by Japanese Pharmacy will have a major impact on the pharmacy industry. We hope that it will support the health of more patients and lead to further improvements in the quality of medical care in Japan! [About Nippon Chouzai Co., Ltd.] https://www.nicho.co.jp/ Since our founding in 1980, we have consistently pursued the “separation of pharmaceutical duties” and actively expanded the development of dispensing pharmacies in order to fulfill the functions and roles that a dispensing pharmacy should play in supporting the national health insurance system. Currently, we have established dispensing pharmacies in all prefectures and employ approximately 4,000 pharmacists, earning us a reputation as one of Japan’s leading dispensing pharmacy companies. Furthermore, in addition to efforts to popularize generic drugs and home medical care, we have been proactively investing in ICT from an early stage, and will continue to provide high-quality and innovative medical services needed in a super-aging society. [About Corte Co., Ltd.] https://hp1.corteai.jp/ Corte Co., Ltd. was established in August 2023 as a generative AI x healthcare company with the corporate philosophy of “Exploring the future of medical care with AI and creating a tomorrow for patients.” This is a venture company headed by Masuzawa, a graduate of the Faculty of Law at the University of Tokyo. In May 2024, we developed Japan’s first AI drug history creation service, “corte,” and as a top runner in this field, we continue to increase the number of contracts. We plan to continue developing AI services that will benefit patients and the medical industry. [About Solamichi System Co., Ltd.] Established in 2018 as a subsidiary of MTI Co., Ltd., with the aim of eliminating unreasonableness and waste in medical care and providing medical care optimized for each individual through initiatives such as developing a medical information network. In 2019, we started providing cloud electronic drug history “CARADA electronic drug history Solamichi” that promotes DX in pharmacies. We provide navigation and support for pharmacist operations. Click here for “CARADA Electronic Medical History Solamichi”:
https://bit.ly/site_solamichi_20211216 *1: “Corte” is a patent pending from Corte Co., Ltd. *2: The total number of pharmacy contracts for the AI drug history creation support service “corte” alone and the AI voice input function “corte” installed in “CARADA electronic drug history Solamichi”. *3: “corte” is a service for creating minutes of conversations between pharmacists and patients. Because it summarizes actual conversations, the generated sentences may not meet the requirements for drug history, depending on the content of the conversation. A pharmacist needs to confirm that the summarized information is appropriate. *4: SOAP format is one of the medical record writing methods in the medical and nursing fields. Write according to the following four items: “S (subjective): subjective information”, “O (objective): objective information”, “A (assessment): evaluation”, and “P (plan): plan”. *CARADA is a trademark or registered trademark of MTI Co., Ltd. *Solamichi is a registered trademark of Solamichi System Co., Ltd. *Corte is a registered trademark of Corte Co., Ltd. *ChatGPT and GPT are trademarks of OpenAI, Inc.